CB2 Insights

CB2 takes huge leap forward signing agreement with Premier Health Group

CB2 Insights (CSE:CBII) CEO Prad Sekar joined Steve Darling from Proactive Investors Vancouver on Skype from Toronto to share news the company has signed an agreement with the British Columbia based Premier Health Group to use the industry’s only medical cannabis-specific Clinical Decision Support tool.

This deal gives CB2 access to 4600 physicians and data gathered from over 300 thousand patients. 

Quick facts: CB2 Insights

Price: $0.14

Market: CSE
Market Cap: $11.03 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CB2 Insights named herein, including the promotion by the Company of CB2 Insights in any Content on the Site, the Company receives from said...



Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

15 hours, 28 minutes ago

2 min read